Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and treatment.
Oslo Cancer Cluster is a national non-profit member organization with 90+ members.
The member base comprises university hospitals, research centers, patient organizations, start-ups and biotech companies, global pharma and technology companies, investors, financial institutions as well as service providers – all working in the cancer field.
Jointly, they cover the entire oncology value chain – from exploratory research to delivering novel therapeutics and diagnostics to patients worldwide.
In 2007, Oslo Cancer Cluster became a Norwegian Centre of Expertise. Since then, the cluster has become a strong biotech cluster well positioned in the global oncology industry.
The world class research environment in cancer immunotherapy, a growing pipeline of preclinical and clinical stage assets and the presence of several pharmaceutical, technology and IT companies, strengthen the cluster’s position as an international knowledge and innovation hub in the cancer field.
RADFORSK was instrumental in establishing Oslo Cancer Cluster in 2006. The cluster is an essential instrument for RADFORSK to execute its vision: “To accelerate commercialisation of cancer and oncology research.”
Jónas Einarsson, CEO in Radforsk, is an Honourable Member of the Board of Oslo Cancer Cluster. Einarsson is the founder and former CEO and Chairman of the board of the cluster.
Oslo Cancer Cluster Incubator accelerates development of cancer diagnostics and therapies by facilitating a comprehensive cancer innovation ecosystem.
The Incubator is an integrated part of Oslo Cancer Cluster Innovation Park and located next to the Institute of Cancer Research, Oslo University Hospital, Radiumhospitalet and Ullern Upper Secondary School.
The Incubator provides a dynamic, creative and professional growth environment for scientists and start ups, as well as an inspirational campus for students with ambitions in life science.
A dedicated team offers members of the Incubator research facilities, business development services and access to an extensive international network of key investors and industrial players.
The Incubator holds 5 000 square metres of offices and laboratories including start ups, global pharma, consultants, service providers, investors and research institutions. A wide range of meeting room and auditorium facilities are available on request.
The Incubator is supported by the Norwegian government to establish health care business in Norway.
The Incubator is owned by RADFORSK, Oslo Cancer Cluster, Siva and Inven2. The Incubator is an essential instrument for RADFORSK in bringing a variety of oncology industry players, from investors to start-ups, together.
Jónas Einarsson, CEO RADFORSK, is a member of the Board since 2020.
Oslo Cancer Cluster Innovation Park is a power centre for the development of new cancer treatments.
The Oslo Cancer Cluster Innovation Park is situated right next to the Norwegian Radium Hospital and the Institute of Cancer Research at Oslo University Hospital. The Innovation Park gathers the whole value chain from basic research to industry within oncology together at one place, the Radium Hospital Innovation Campus.
Oslo Cancer Cluster Innovation Park is a unique project and is built on private enthusiasm and the long history of excellent cancer research and treatment performed at the Norwegian Radium Hospital.
Purely focused on oncology and housing an oncology Incubator, the Oslo Cancer Cluster Innovation Park will ensure that bright ideas in the lab reach the cancer patients faster than today.
Pupils at Ullern have a rare chance to receive guest lectures from oncology researchers and industry leaders, do internships at Oslo University Hospital and the other members of Oslo Cancer Cluster. The collaboration between Ullern Upper Secondary School and Oslo Cancer Cluster started in 2009 and is expanding every year .
The 36 000 m² Innovation Park opened in September 2015. Located next to the Norwegian Radium Hospital and the Institute for Cancer Research at Oslo University Hospital, The Innovation Park – comprising the Oslo Cancer Cluster, Ullern High School and Oslo Cancer Cluster Incubator – co-locates education, research and industry at a joint innovation campus in Oslo. The Innovation Park thus creates synergies across the entire oncology-value chain.